Seres Therapeutics, Inc. (MCRB) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Seres Therapeutics, Inc. (MCRB): 1Y return -55.3%, Sharpe ratio -0.28, volatility 97.7%, max drawdown -80.4%. A Stock in the Equity asset class. Compare MCRB with other assets and invest through your own broker with pfolio.
Seres Therapeutics, Inc. (MCRB) Overview
- Type: Stock
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
MCRB Performance
- MTD
- Return: -28.8%, Sharpe: -9.91, Volatility: 90.2%, Max Drawdown: -31.0%
- YTD
- Return: -62.2%, Sharpe: -1.61, Volatility: 84.2%, Max Drawdown: -65.0%
- 1Y
- Return: -55.3%, Sharpe: -0.28, Volatility: 97.7%, Max Drawdown: -80.4%
- 5Y
- Return: -98.7%, Sharpe: -0.25, Volatility: 103.3%, Max Drawdown: -98.7%
- 10Y
- Return: -99.1%, Sharpe: 0.15, Volatility: 151.5%, Max Drawdown: -99.3%
Frequently Asked Questions
- What is Seres Therapeutics, Inc. (MCRB)?
- Seres Therapeutics, Inc. (MCRB) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does MCRB compare to other assets?
- You can compare MCRB with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in MCRB through pfolio?
- pfolio helps you build diversified portfolios that may include MCRB. You invest through your own broker — pfolio provides the analytics.